ReviewFrontiers in cardiovascular medicine2026

Closing the diagnostic gap in transthyretin cardiac amyloidosis: red flags, modern imaging, and emerging therapies.

Zhengjun Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.